Disease-Modifying Drug Regimen May Offer Benefit in Heart Failure

THURSDAY, May 28, 2020 -- The treatment effects of early comprehensive disease-modifying pharmacological therapy are considerable for patients with heart failure with reduced ejection fraction (HFrEF), according to a study published online May 21 in...